Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine/Caffeine and Pioglitazone in Obesity
NCT00377975Phase 2Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ephedrine, caffeine, pioglitazone in obesity, sponsored by Pennington Biomedical Research Center. Started Jan 2003; status: completed.
02
Drugs
ephedrinecaffeinepioglitazone
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00377975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377975.